Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Feb 29, 2024 | (FY)Feb 28, 2023 | (FY)Feb 28, 2022 | (FY)Feb 28, 2021 | (FY)Feb 29, 2020 | (FY)Feb 28, 2019 | (FY)Feb 28, 2018 | (FY)Feb 28, 2017 | (FY)Feb 29, 2016 | (FY)Feb 28, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 7.22%393.36M | 1.14%366.87M | -34.02%362.72M | 61.20%549.76M | 69.65%341.05M | -47.90%201.03M | -21.12%385.89M | 32.08%489.23M | 10.30%370.4M | 335.82M |
Net profit before non-cash adjustment | -18.43%285.29M | -6.47%349.74M | 20.73%373.93M | 5.67%309.72M | -13.43%293.11M | -65.24%338.58M | 141.22%973.98M | 23.85%403.78M | 81.97%326.01M | --179.15M |
Total adjustment of non-cash items | 337.21%154.6M | 13.20%35.36M | -20.06%31.24M | -63.66%39.08M | 307.33%107.53M | 104.44%26.4M | -9,021.14%-594.95M | -92.54%6.67M | 1.39%89.41M | --88.19M |
-Depreciation and amortization | 151.75%119.94M | -3.40%47.64M | -10.78%49.32M | -9.52%55.28M | 14.18%61.09M | 5.52%53.51M | 15.75%50.71M | 56.13%43.81M | -59.31%28.06M | --68.95M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --17.43M | ---- | ---- | ---- | --10.84M | ---- | --6.51M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 10.21%15.67M | --14.22M |
-Share of associates | -60.87%340K | -90.35%869K | 279.65%9.01M | --2.37M | ---- | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | 289.30%48.53M | 50.18%-25.63M | -1,082.33%-51.46M | -199.11%-4.35M | -32.80%4.39M | 101.06%6.53M | -13,951.95%-617.58M | -134.51%-4.4M | 172.92%12.74M | --4.67M |
-Net exchange gains and losses | ---- | ---- | ---- | ---- | 259.17%2.16M | --600K | ---- | ---- | ---- | ---- |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.96%8.72M | --8.31M |
-Other non-cash items | -213.79%-14.2M | -48.76%12.48M | 176.99%24.36M | -179.34%-31.65M | 216.49%39.89M | -21.97%-34.24M | 35.59%-28.08M | -279.92%-43.59M | 267.39%24.23M | ---14.47M |
Changes in working capital | -155.21%-46.53M | 57.04%-18.23M | -121.12%-42.44M | 437.25%200.96M | 63.65%-59.59M | -2,487.04%-163.94M | -91.28%6.87M | 274.98%78.78M | -165.75%-45.03M | --68.48M |
-Change in receivables | 75.16%-23.79M | -198.33%-95.76M | -10.91%97.39M | 176.94%109.32M | -375.55%-142.08M | 429.06%51.56M | 62.53%-15.67M | -141.04%-41.82M | 57.66%-17.35M | ---40.98M |
-Change in inventory | 52.93%-7.84M | -596.95%-16.66M | -106.92%-2.39M | 1,011.29%34.55M | 113.79%3.11M | 7.90%-22.55M | -1,202.23%-24.48M | 68.51%-1.88M | 57.54%-5.97M | ---14.06M |
-Change in payables | -139.80%-28.3M | 146.67%71.12M | -166.25%-152.39M | 277.11%230.01M | 129.58%60.99M | -744.77%-206.18M | -66.87%31.98M | 534.36%96.51M | -120.00%-22.22M | --111.08M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.05%515K | --26.45M |
-Provision for loans, leases and other losses | -41.91%13.41M | 54.33%23.08M | 108.65%14.95M | -1,040.20%-172.91M | 39.10%18.39M | -12.11%13.22M | 0.64%15.04M | --14.95M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.03M | ---- | ---14M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 5.87%-3.82M | 10.97%-4.06M | 18.31%-4.56M | 18.13%-5.58M | -21.75%-6.81M | -4.83%-5.6M | 64.99%-5.34M | -2.18%-15.24M | -20,819.44%-14.92M | 72K |
Interest received (cash flow from operating activities) | -0.06%5.01M | 0.00%5.01M | -0.02%5.01M | -0.61%5.01M | 0.32%5.04M | -2.80%5.03M | -2.10%5.17M | -3.59%5.28M | 109,720.00%5.48M | -5K |
Tax refund paid | 15.14%-108.89M | 7.13%-128.32M | -42.52%-138.18M | -38.43%-96.95M | 65.86%-70.04M | -29.62%-205.13M | 8.13%-158.25M | -121.89%-172.26M | 25.56%-77.63M | -104.29M |
Other operating cash inflow (outflow) | 0 | 0 | 200.00%1K | 0.00%-1K | 99.97%-1K | 79.03%-3M | -14.3M | 0 | -100.02%-1K | 4.56M |
Operating cash flow | 19.27%285.66M | 6.45%239.51M | -50.25%225M | 67.97%452.24M | 3,614.93%269.24M | -103.59%-7.66M | -30.56%213.18M | 8.36%307.01M | 19.97%283.33M | --236.16M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -888.52%-37.3M | 63.98%-3.77M | -115.26%-10.48M | 1,056.81%68.66M | 49.13%-7.18M | -101.43%-14.11M | 398.72%986.05M | -7.90%-330.1M | 72.86%-305.92M | ---1.13B |
Net intangibles purchase and sale | -1,880.00%-348.36M | -263.44%-17.59M | 50.57%-4.84M | -172.18%-9.79M | 67.38%-3.6M | 6.79%-11.03M | -51.02%-11.83M | -258.14%-7.84M | 30.07%-2.19M | ---3.13M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---11.47M | ---- | ---- | ---- | ---129.31M |
Net investment property transactions | ---- | ---- | ---- | -3.78%3.44M | -7.69%3.58M | 8.33%3.87M | -7.69%3.58M | --3.87M | ---- | ---- |
Net investment product transactions | 172.58%24.66M | -1,042.82%-33.98M | -123.57%-2.97M | 417.81%12.61M | 95.13%-3.97M | -11.54%-81.58M | -282.19%-73.14M | 2,000.71%40.14M | -116.93%-2.11M | --12.47M |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---21.9M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | -21.23%2.87M | -25.80%3.64M | 12,167.50%4.91M | --40K |
Dividends received (cash flow from investment activities) | --6.43M | --0 | --53.25M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Net changes in other investments | 83,723.53%14.25M | 100.17%17K | -197.35%-10.21M | 284.08%10.49M | -234.00%-5.7M | -310.10%-1.71M | -102.01%-416K | -71.67%20.73M | 740.31%73.17M | --8.71M |
Investing cash flow | -515.12%-340.32M | -323.59%-55.33M | -71.03%24.74M | 606.45%85.41M | 85.46%-16.87M | -112.79%-116.02M | 436.53%907.11M | -16.11%-269.55M | 81.58%-232.14M | ---1.26B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 0.00%-59.4M | 0.00%-59.4M | -6.72%-59.4M | 8.34%-55.66M | 30.35%-60.73M | 89.47%-87.19M | -537.03%-828.42M | -245.62%-130.04M | -93.57%89.3M | --1.39B |
Net common stock issuance | --0 | 106.94%12M | -533.93%-172.99M | -228.62%-27.29M | 160.06%21.22M | -801.45%-35.33M | -98.56%5.04M | --349.6M | ---- | --102.9M |
Cash dividends paid | 6.15%-76.53M | -0.95%-81.54M | 0.84%-80.78M | 1.26%-81.47M | -2.54%-82.51M | -9.65%-80.46M | -72.66%-73.38M | -25.00%-42.5M | -3.03%-34M | ---33M |
Net other fund-raising expenses | ---- | --1K | ---- | ---1K | ---- | ---- | ---1K | ---- | ---- | ---- |
Financing cash flow | -5.42%-135.93M | 58.83%-128.95M | -90.47%-313.17M | -34.75%-164.42M | 39.89%-122.02M | 77.37%-202.98M | -606.48%-896.76M | 220.16%177.06M | -96.21%55.3M | --1.46B |
Net cash flow | ||||||||||
Beginning cash position | 3.45%1.66B | -3.81%1.6B | 28.89%1.67B | 11.22%1.29B | -21.95%1.16B | 17.68%1.49B | 20.43%1.26B | 11.29%1.05B | 85.27%943.53M | --509.27M |
Current changes in cash | -445.06%-190.59M | 187.08%55.24M | -116.99%-63.43M | 186.31%373.24M | 139.91%130.36M | -246.14%-326.65M | 4.19%223.52M | 101.45%214.52M | -75.48%106.49M | --434.26M |
Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Cash adjustments other than cash changes | 0.00%-1K | ---1K | ---- | 200.00%1K | 50.00%-1K | ---2K | ---- | --1K | ---- | --1K |
End cash Position | -11.50%1.47B | 3.45%1.66B | -3.81%1.6B | 28.89%1.67B | 11.22%1.29B | -21.95%1.16B | 17.68%1.49B | 20.43%1.26B | 11.29%1.05B | --943.53M |
Free cash flow | -145.84%-100M | 4.03%218.14M | -51.41%209.68M | 66.95%431.51M | 888.11%258.47M | -117.82%-32.8M | 553.86%184.06M | 10.44%-40.55M | 94.94%-45.28M | ---894.1M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |